These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 24247291

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dabigatran and postmarketing reports of bleeding.
    Southworth MR, Reichman ME, Unger EF.
    N Engl J Med; 2013 Apr 04; 368(14):1272-4. PubMed ID: 23484796
    [No Abstract] [Full Text] [Related]

  • 3. Dabigatran, bleeding, and the regulators.
    Moore TJ, Cohen MR, Mattison DR.
    BMJ; 2014 Jul 23; 349():g4517. PubMed ID: 25056265
    [No Abstract] [Full Text] [Related]

  • 4. The trouble with dabigatran.
    Charlton B, Redberg R.
    BMJ; 2014 Jul 23; 349():g4681. PubMed ID: 25055830
    [No Abstract] [Full Text] [Related]

  • 5. Multiple data sources, the best way to gather safety information about medications.
    Katz MH.
    JAMA Intern Med; 2014 Jan 23; 174(1):151. PubMed ID: 24248326
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Is there really misuse and abuse of dabigatran?
    Eikelboom JW, Hankey GJ.
    Med J Aust; 2013 Apr 15; 198(7):358-9. PubMed ID: 23581946
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bleeding risk with dabigatran in the frail elderly.
    Harper P, Young L, Merriman E.
    N Engl J Med; 2012 Mar 01; 366(9):864-6. PubMed ID: 22375994
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The importance of postapproval data for dabigatran.
    Redberg RF.
    JAMA Intern Med; 2015 Jan 01; 175(1):25. PubMed ID: 25365377
    [No Abstract] [Full Text] [Related]

  • 13. Gastrointestinal bleeding. Gastrointestinal bleeding risk is increased by novel anticoagulants.
    Rockey DC.
    Nat Rev Gastroenterol Hepatol; 2015 Mar 01; 12(3):131-2. PubMed ID: 25601661
    [Abstract] [Full Text] [Related]

  • 14. [New oral anticoagulants and digestive hemorrhages].
    Diallo I, Mallaret C, Jourdan S, Brardjanian S, Guisset M, Coton T.
    Presse Med; 2014 Jan 01; 43(1):85-7. PubMed ID: 23706679
    [No Abstract] [Full Text] [Related]

  • 15. The promise of pharmacoepidemiology in helping clinicians assess drug risk.
    Avorn J.
    Circulation; 2013 Aug 13; 128(7):745-8. PubMed ID: 23940388
    [No Abstract] [Full Text] [Related]

  • 16. Dabigatran: uncharted waters and potential harms.
    Radecki RP.
    Ann Intern Med; 2012 Jul 03; 157(1):66-8. PubMed ID: 22751762
    [No Abstract] [Full Text] [Related]

  • 17. Dabigatran: how the drug company withheld important analyses.
    Cohen D.
    BMJ; 2014 Jul 23; 349():g4670. PubMed ID: 25055829
    [No Abstract] [Full Text] [Related]

  • 18. [Dabigatran and risk of bleeding].
    Hasler S.
    Praxis (Bern 1994); 2015 Jan 28; 104(3):157-8. PubMed ID: 25626386
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Risk of Bleeding With Dabigatran in 2010-2011 Medicare Data.
    Hernandez I, Zhang Y.
    JAMA Intern Med; 2015 Jul 28; 175(7):1245-7. PubMed ID: 26146922
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.